Table 2.
Clinical and virological characteristics of subjects recruited in the study.
| Parameters | Non-HBV-HCC | HBV-HCC | CHBV |
P value |
|---|---|---|---|---|
| *Non-HBV-HCC vs. HBV-HCC **HBV-HCC vs. CHBV |
||||
| Age (years), mean ± SD | 59 ± 8.5 | 54 ± 10 | 36 ± 13.6 | NS |
| Sex (M:F) | 17 : 5 | 14 : 3 | 9 : 1 | NS |
| AST (IU/ml), median (range) | 97.5 (71–763) | 109.5 (73–229) | 70.5 (41–966) | NS |
| ALT (IU/ml), median (range) | 73 (51–402) | 71 (51–229) | 72 (46–872) | NS |
| HBsAg | Non-reactive | Reactive | Reactive | – |
| HBeAg | – | – | Reactive | – |
| AFP (ng/ml), median (range) | 13.5 (2.4–18,900) | 943.5 (2.24–575736.6) | 38.2 (2.45–120.6) | 0.047*, 0.045** |
| HBV DNA (IU/ml), median (range) | – | 1645 (77.6–7.52 × 106) | 20.6 × 106 (10–1.10 × 108) | 0.04** |
*P value: Non-HBV-HCC vs. HBV-HCC; **P value: HBV-HCC vs. CHBV.